Effects of arecoline on proliferation of oral squamous cell carcinoma cells by dysregulating c-Myc and miR-22, directly targeting oncostatin M

miR-22 regulates cell invasion, migration and proliferation in vitro through inhibiting CD147 expression in tongue squamous cell carcinoma

(2016) Kaifeng Qiu et al.   ARCHIVES OF ORAL BIOLOGY

Activities of E6 Protein of Human Papillomavirus 16 Asian Variant on miR-21 Up-regulation and Expression of Human Immune Response Genes

(2015) Peechanika Chopjitt et al.   Asian Pacific Journal of Cancer Prevention

Up-Regulation of miR-21 Is Associated with Cervicitis and Human Papillomavirus Infection in Cervical Tissues

(2015) Sureewan Bumrungthai et al.   PLoS One

A Regulatory Loop Involving miR-22, Sp1, and c-Myc Modulates CD147 Expression in Breast Cancer Invasion and Metastasis

(2014) L.-M. Kong et al.   CANCER RESEARCH

HiJAK’d Signaling; the STAT3 Paradox in Senescence and Cancer Progression

(2014) Damian Junk et al.   Cancers

Stat3-coordinated Lin-28–let-7–HMGA2 and miR-200–ZEB1 circuits initiate and maintain oncostatin M-driven epithelial–mesenchymal transition

(2013) L Guo et al.   ONCOGENE

Role of interleukin-6 in Barrett’s esophagus pathogenesis

(2013) Katerina Dvorak   WORLD JOURNAL OF GASTROENTEROLOGY

Oncostatin M suppresses oestrogen receptor-α expression and is associated with poor outcome in human breast cancer

(2012) Nathan R West et al.   ENDOCRINE-RELATED CANCER

Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3

(2012) Bo Ling et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Clinical significance of miR-22 expression in patients with colorectal cancer

(2012) Guangjun Zhang et al.   MEDICAL ONCOLOGY

Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines

(2011) Stacey L Fossey et al.   BMC CANCER

The Unholy Trinity: Inflammation, Cytokines, and STAT3 Shape The Cancer Microenvironment

(2011) Ning Li et al.   CANCER CELL

c-MYC Functions as a Molecular Switch to Alter the Response of Human Mammary Epithelial Cells to Oncostatin M

(2011) C. E. Kan et al.   CANCER RESEARCH

Tumor Suppressor miR-22 Determines p53-Dependent Cellular Fate through Post-transcriptional Regulation of p21

(2011) N. Tsuchiya et al.   CANCER RESEARCH

miR-22 represses cancer progression by inducing cellular senescence

(2011) Dan Xu et al.   JOURNAL OF CELL BIOLOGY

Areca Nut Induces miR-23a and Inhibits Repair of DNA Double-Strand Breaks by Targeting FANCG

(2011) Yi-Shan Tsai et al.   TOXICOLOGICAL SCIENCES

An estrogen receptor α suppressor, microRNA-22, is downregulated in estrogen receptor α-positive human breast cancer cell lines and clinical samples

(2010) Jianhua Xiong et al.   FEBS Journal

Intercountry prevalences and practices of betel-quid use in south, southeast and eastern asia regions and associated oral preneoplastic disorders: An international collaborative study by asian betel-quid consortium of south and east Asia

(2010) Chien-Hung Lee et al.   INTERNATIONAL JOURNAL OF CANCER

Characterization of 5-Fluorouracil-Resistant Cholangiocarcinoma Cell Lines

(2008) Nisana Namwat et al.   CHEMOTHERAPY

Relationship between responsiveness of cancer cells to Oncostatin M and/or IL-6 and survival of stage III melanoma patients treated with tumour-infiltrating lymphocytes

(2008) A Lacreusette et al.   JOURNAL OF PATHOLOGY

Arecoline, a major alkaloid of areca nut, inhibits p53, represses DNA repair, and triggers DNA damage response in human epithelial cells

(2008) Yi-Shan Tsai et al.   TOXICOLOGY